StocksMedium•5 November 2026•
1 min read
Adaptive Biotechnologies Reports Surprise Q3 Profit Beating Estimates
Key Facts
1Adaptive Biotechnologies reported quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a $0.1 loss per share.
2The results show a significant improvement compared to a loss of $0.15 per share reported in the same quarter a year ago.
Adaptive Biotechnologies reported quarterly earnings of $0.02 per share for the third quarter of 2026. Zacks reported that these results beat the consensus estimate of a $0.1 loss per share, driven by revenue growth that exceeded expectations.
The performance represents a significant improvement from the loss of $0.15 per share recorded in the same quarter a year ago. ADPT closed at $26.71 on November 4, 2026, with the stock trading between a low of $25.19 and a high of $26.88 during that session.